Submit project

Fo consider the project complete the form. Private and contact information will hidden.
Your name
Your Email
Project title
Project amount
Project description
Please, be as precise as possible in your descriptions. This will help to avoid misunderstandings and unnecessary clarifications.

Bioengineering Rehabilitation for Wounded

Japanese scientists planning mass production of blood stem cells

A group of Japanese scientists plan by 2020 the mass production of artificial blood using induced pluripotent stem cells (iPS-cells).
The company, Megakaryon failed in April this year, to create the first successful examples. The president of the corporation Genjiro Miwa began work on the creation of artificial blood in 2008, together with  University of Tokyo professor Hiromistu Nakauch, and professor at Kyoto University Koji Eto.

Scientists complained that medical progress was often hampered by the fact new technology can not be put on a commercial footing. “Scientists do not always know how to monetize their research. We need to bring someone from the business world, except Japan seriously lags behind foreign competitors in this field,” Nakauch said.

Animation of red blood cells

According to the developers of the technology, the production of artificial blood is essential for medicine in terms of population aging, through which the number of potential donors dramatically decreases. This technology is also important for doctors in those regions of the world where there is insufficient infrastructure for organizing blood transfusion stations.

Currently Megakaryon is able to produce only small amounst of artificial blood – hundreds of thousands of times smaller than the real needs of medical institutions.
After the Japanese scientist Sin’ya Yamanaka won the Nobel Prize for medicine and physiology for research into stem cells in 2012, interest in the subject, both in Japanese society, and from the Japanese government rapidly increased. Regenerative medicine has been declared one of the priorities of science.

in news

Ukraine also has made great achievements in the development and application of cellular technology. Ukrainian biotechnology has restored bone, tissue and nerve cells. This technology is being used to restore damaged joints and limbs in injured ATO soldiers, returning them to function and mobility. This technology is offered by only a few clinics throughout the world, including in Ukraine. Ilaya Medical Company and The People’s Project, as part of Bioengineering Rehabilitation for Wounded initiative, the latest biotechnology is being used restore the damaged limbs of wounded Ukrainian soldiers.

Earlier, The People’s Project reported the incredible restoration of the bone in a 19-year-old’s leg. Recently doctors formed new bone in a wounded soldier from the “Donbas” Battalion.

Currently the collection of funds for the treatment of five wounded is underway and four more are waiting in line to join the project. For them biotechnology represents their only chance for recovery. Since the state, through legislative and other restrictions, can not support biotechnology in the treatment of wounded soldiers, their only hope lies with people.

We ask you to get involved and help Ukraine’s defenders.

Donate to other projects
Founds raised Treatment continues

Bioengineering Rehabilitation for Wounded

Regeneration of bone and tissue loss, sustained through mechanical or gunshot wounds through application of ilaya.regeneration stem cell technology

30 520 391 UAH (834 606 USD) needed
100% raised
Read more
Реквізити ПриватБанку для переказу у гривнях
Миколаївський обласний благодійний фонд “РЕГІОНАЛЬНИЙ ФОНД БЛАГОЧЕСТЯ”
ПАО КБ ПриватБанк
ЄДРПОУ: 36143302
МФО: 305299
IBAN-код:
Призначення платежу: Благодійний внесок. “”
USD
Beneficiary: Mykolayiv Regional Charitable Foundation “Regional Foundation Blagochestya”
IBANcode: UA583052990000026007011702069
Beneficiary address: UA 54000, Mykolaiv, Buznyka str. 5, 118
Beneficiary bank: Privatbank
50, Naberezhna Peremogy Street, Dnipropetrovsk, 49094, Ukraine
Swift code: PBANUA2X

Intermediary bank: JP Morgan Chase Bank,New York ,USA
Swift code: CHASUS33
Correspondent account: 001-1-000080
Description: Charitable donation for ‘’ project
or
Intermediary bank: The Bank of New York Mellon, New York, USA
Swift code: IRVT US 3N
Correspondent account: 890-0085-754
Description: Charitable donation for ‘’ project
EUR
Beneficiary: Mykolayiv Regional Charitable Foundation “Regional Foundation Blagochestya”
IBANcode: UA703052990000026002041702959
Beneficiary address: UA 54000, Mykolaiv, Buznyka str. 5, 118
Beneficiary bank: Privatbank
50, Naberezhna Peremogy Street, Dnipropetrovsk, 49094, Ukraine
Swift code: PBANUA2X

Intermediary bank: Commerzbank AG ,Frankfurt am Main, Germany
Swift code: COBADEFF
Correspondent account: 400886700401
Description: Charitable donation for ‘’ project
PLZ
Beneficiary: Mykolayiv Regional Charitable Foundation "Regional Foundation Blagochestya"
IBAN Code: UA363052990000026006001705679
Name of the bank: JSC CB "PRIVATBANK", 1D HRUSHEVSKOHO STR., KYIV, 01001, UKRAINE
Bank SWIFT Code: PBANUA2X
Beneficiary address: UA 54000, Mykolaiv, Buznyka str. 5, 118
CORRESPONDENT BANK: Bank Pekao/Grupa Pekao S.A., Warsaw, Poland
Account in the correspondent bank: PL13124000013140533111120301
SWIFT Code of the correspondent bank: PKOPPLPW
Description: Charitable donation for "" project.
GBP
Beneficiary: Mykolayiv Regional Charitable Foundation “Regional Foundation Blagochestya”
IBANcode: UA583052990000026007011702069
Beneficiary address: UA 54000, Mykolaiv, Buznyka str. 5, 118
Beneficiary bank: Privatbank
50, Naberezhna Peremogy Street, Dnipropetrovsk, 49094, Ukraine
Swift code: PBANUA2X

Intermediary bank: JP Morgan Chase Bank,New York ,USA
Swift code: CHASUS33
Correspondent account: 001-1-000080
Description: Charitable donation for ‘’ project
or
Intermediary bank: The Bank of New York Mellon, New York, USA
Swift code: IRVT US 3N
Correspondent account: 890-0085-754
Description: Charitable donation for ‘’ project

Press about us

Partners